Claudia Stege

Research output

Research output per year 2017 2017 2020 2021 2022 2023 2023

• 7 Article
• 2 Comment/Letter to the editor
• 1 Book
• 1 Chapter
• 5 More
  • 1 Meeting Abstract
  • 1 Letter
  • 1 Short survey
  • 1 Review article
  • 1 Phd-Thesis - Research and graduation internal

Research output per year

Research output per year

Search results

• 2023

  Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL

  HOVON CLL Working Group, 28 Sept 2023, In: Blood. 142, 13, p. 1131-1142 12 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  4 Citations (Scopus)

• Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial

  Groen, K., Stege, C. A. M., Nasserinejad, K., de Heer, K., van Kampen, R. J. W., Leys, R. B. L., Thielen, N., Westerman, M., Wu, K-L., Ludwig, I., Issa, D. E., Velders, G. A., Vekemans, M-C., Timmers, G-J., de Boer, F., Tick, L. W., Verbrugge, A., Buitenhuis, D., Cunha, S. M., van der Spek, E., & 9 othersde Waal, E. G. M., Sohne, M., Sonneveld, P., Nijhof, I. S., Klein, S. K., van de Donk, N. W. C. J., Levin, M-D., Ypma, P. F. & Zweegman, S., 1 Sept 2023, In: EClinicalMedicine. 63, 102167.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  2 Citations (Scopus)

• Treatment of older patients with multiple myeloma: towards a frailty approach

  Stege, C. A. M., 16 Feb 2023, s.l.: Ridderprint. 282 p.

  Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

  Open Access
• 2022

  Impact of Comorbidities on Health-related Quality of Life in Nontransplant Eligible Patients with Newly Diagnosed Multiple Myeloma

  Bennink, M. C., Stege, C. A. M., Lissenberg-Witte, B. I., Oerlemans, S., Seefat, M. R., Sonneveld, P. & Zweegman, S., 21 Jul 2022, In: HemaSphere. 6, 7, p. E744

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  1 Citation (Scopus)

• Midostaurin as the Most Likely Cause of Bilateral Adrenal Masses in a Patient with Acute Myeloid Leukemia

  Schutte, T., Stege, C. A. M., Smits, M. M., Franssen, L. E., Donker, M. L. & de Leeuw, D. C., 2022, (E-pub ahead of print) In: Clinical drug investigation.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
• 2021

  Improving the identification of frail elderly newly diagnosed multiple myeloma patients

  Stege, C. A. M., Nasserinejad, K., Klein, S. K., Timmers, G. J., Hoogendoorn, M., Ypma, P. F., Nijhof, I. S., Velders, G. A., Strobbe, L., Durdu-Rayman, N., Westerman, M., Davidis-van Schoonhoven, M. A., van Kampen, R. J. W., Beeker, A., Koster, A., Dijk, A. C., van de Donk, N. W. C. J., van der Spek, E., Leys, R. B. L., Silbermann, M. H., & 9 othersGroen, K., van der Burg-de Graauw, N. C. H. P., Sinnige, H. A. M., van der Hem, K. G., Levenga, H., Bilgin, Y. M., Sonneveld, P., Levin, M. D. & Zweegman, S., Sept 2021, In: Leukemia. 35, 9, p. 2715-2719 5 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  4 Citations (Scopus)

• Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study

  Stege, C. A. M., Nasserinejad, K., van der Spek, E., Bilgin, Y. M., Kentos, A., Sohne, M., van Kampen, R. J. W., Ludwig, I., Thielen, N., Durdu-Rayman, N., de Graauw, N. C. H. P., van de Donk, N. W. C. J., de Waal, E. G. M., Vekemans, M. C., Timmers, G. J., van der Klift, M., Soechit, S., Geerts, P. A. F., Silbermann, M. H., Oosterveld, M., & 5 othersNijhof, I. S., Sonneveld, P., Klein, S. K., Levin, M. D. & Zweegman, S., 1 Sept 2021, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39, 25, p. 2758-2767 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  21 Citations (Scopus)

• RE: Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living with Cancer Study

  Dekker, J., Stege, C. A. M. & Versteeg, K. S., 1 Oct 2021, In: Journal of the National Cancer Institute. 113, 10, p. 1434-1435 2 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  2 Citations (Scopus)
• 2020

  Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma

  Mian, H., Grant, S. J., Engelhardt, M., Pawlyn, C., Bringhen, S., Zweegman, S., Stege, C. A. M., Rosko, A. E., von Lilienfeld-Toal, M. & Wildes, T. M., Jun 2020, In: Journal of geriatric oncology. 11, 5, p. 764-768 5 p.

  Research output: Contribution to journal › Short survey › Academic › peer-review

  Open Access
  18 Citations (Scopus)

• Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study

  Nielsen, L. K., Stege, C., Lissenberg-Witte, B., van der Holt, B., Mellqvist, U-H., Salomo, M., Bos, G., Levin, M-D., Visser-Wisselaar, H., Hansson, M., van der Velden, A., Deenik, W., Coenen, J., Hinge, M., Klein, S., Tanis, B., Szatkowski, D., Brouwer, R., Westerman, M., Leys, R., & 10 othersSinnige, H., Haukås, E., van der Hem, K., Durian, M., Gimsing, P., van de Donk, N., Sonneveld, P., Waage, A., Abildgaard, N. & Zweegman, S., 1 Jun 2020, In: Haematologica. 105, 6, p. 1650-1659 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  19 Citations (Scopus)

• Validation of the FIRST simplified frailty scale using the ECOG performance status instead of patient-reported activities

  Stege, C. A. M., van der Holt, B., Dinmohamed, A. G., Sonneveld, P., Levin, M. D., van de Donk, N. W. C. J., Mellqvist, U. H., Waage, A. & Zweegman, S., 1 Jul 2020, In: Leukemia. 34, 7, p. 1964-1966 3 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  19 Citations (Scopus)
• 2019

  Carfilzomib for relapsed and refractory multiple myeloma

  Groen, K., van de Donk, N., Stege, C., Zweegman, S. & Nijhof, I. S., 2019, In: Cancer management and research. 11, p. 2663-2675 13 p.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  48 Citations (Scopus)
• 2018

  CD38-targeting antibodies in multiple myeloma: mechanisms of action and clinical experience

  Frerichs, K. A., Nagy, N. A., Lindenbergh, P. L., Bosman, P., Marin Soto, J., Broekmans, M., Groen, R. W. J., Themeli, M., Nieuwenhuis, L., Stege, C., Nijhof, I. S., Mutis, T., Zweegman, S., Lokhorst, H. M. & van de Donk, N. W. C. J., Mar 2018, In: Expert Review of Clinical Immunology. 14, 3, p. 197-206 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  28 Citations (Scopus)
• 2017

  FEASIBILITY AND EFFICACY OF DOSE ADJUSTED MELPHALAN - PREDNISONE - BORTEZOMIB IN PATIENTS >= 75 YEARS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; PRELIMINARY RESULTS OF THE PHASE II HOVON 123 STUDY

  Zweegman, S., Levin, M. -D., Klein, S. K., de Waal, E. G., Eeltink, C. M., Ypma, P. F., Dijk, A. C., Westerman, M., Deenik, W., Tanis, B., Slee-Valentijn, M. S., Minnema, M. C., Visser-Wisselaar, H., Stege, C., van de Donk, N. W., Nasserinejad, K. & Sonneveld, P., 26 Jun 2017, In: Haematologica. 102, p. 112-113

  Research output: Contribution to journal › Meeting Abstract › Academic

• Frailty predicts survival and toxicity in newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation; report of the HOVON-87/NMSG-18 study group

  Stege, C. A. M., Van Der Holt, B., Mellqvist, U. H., Levin, M. D., Salomo, M., Abildgaard, N., Bos, G., Visser-Wisselaar, H., Hansson, M., Van Der Velden, A., Deenik, W., Gruber, A., Coenen, J. L. L. M., Plesner, T., Klein, S., Tanis, B., Szatkowski, D. L., Brouwer, R., Westerman, M., Leijs, M. B., & 11 othersSinnige, H., Haukaas, E., Van Der Hem, K., Durian, M., Mattijssen, V., Gimsing, P., Van De Donk, N. W. C. J., Stevens-Kroef, M., Sonneveld, P., Waage, A. & Zweegman, S., 2017, Blood. Conference: 59th Annual Meeting of the American Society of Hematology, ASH. (Blood. Conference: 59th Annual Meeting of the American Society of Hematology, ASH; vol. 130).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review

• Health-related quality of life in non-transplant eligible newly diagnosed multiple myeloma patients treated with melphalan/prednisolone plus either thalidomide or lenalidomide; results of the HOVON87/NMSG18 study

  Nielsen, L., Stege, C., Witte, B., Holt, B., Mellqvist, U-H., Salomo, M., Levin, M-D., Hansson, M., Plesner, T., Szatkowski, D., Haukas, E., Gimsing, P., Sonneveld, P., Abildgaard, N., Waage, A. & Zweegman, S., 2017, 2 p. (Quality of life research. Conference: 24th annual conference of the international society for quality of life research, ISOQOL 2017. United states; vol. 26)

  Research output: Book/Report › Book › Academic › peer-review